Danny Liaw

Merck & Co., Inc., Rahway, NJ, USA (United States) — United States

Medicine · Health Sciences

11h-index9.0kcitations20works5.02yr avg
OpenAlex↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Atrial Fibrillation Management and Outcomes(9), Antiplatelet Therapy and Cardiovascular Diseases(8), PI3K/AKT/mTOR signaling in cancer(6), Acute Myocardial Infarction Research(5), Cancer Immunotherapy and Biomarkers(2)

Publications20 total

Safety findings from the phase 1/2 MOSAIC study of miransertib for patients with PIK3CA-related overgrowth spectrum or Proteus syndrome
Orphanet Journal of Rare Diseases·2025· 1 citedOpen Access
Paediatric strategy forum for medicinal product development of PI3-K, mTOR, AKT and GSK3β inhibitors in children and adolescents with cancer
European Journal of Cancer·2024· 9 citedOpen Access
ENERGIZE: a Phase III study of neoadjuvant chemotherapy alone or with nivolumab with/without linrodostat mesylate for muscle-invasive bladder cancer
Future Oncology·2019· 90 citedOpen Access
A phase 3 randomized study of neoadjuvant chemotherapy (NAC) alone or in combination with nivolumab (NIVO) ± BMS-986205 in cisplatin-eligible muscle invasive bladder cancer (MIBC).
Journal of Clinical Oncology·2019· 9 cited
An open-Label, 2 × 2 factorial, randomized controlled trial to evaluate the safety of apixaban vs. vitamin K antagonist and aspirin vs. placebo in patients with atrial fibrillation and acute coronary syndrome and/or percutaneous coronary intervention: Rationale and design of the AUGUSTUS trial
American Heart Journal·2018· 86 citedOpen Access
Apixaban following acute coronary syndromes in patients with prior stroke: Insights from the APPRAISE-2 trial
American Heart Journal·2017· 7 cited
Apixaban Plus Mono Versus Dual Antiplatelet Therapy in Acute Coronary Syndromes
Journal of the American College of Cardiology·2015· 46 cited
Characterising and predicting bleeding in high-risk patients with an acute coronary syndrome
Heart·2015· 19 cited
APIXABAN FOLLOWING ACUTE CORONARY SYNDROMES AMONG PATIENTS WITH PRIOR STROKE: INSIGHTS FROM THE APPRAISE-2 TRIAL
Journal of the American College of Cardiology·2015· 1 cited
Anticoagulant therapy and outcomes in patients with prior or acute heart failure and acute coronary syndromes: Insights from the APixaban for PRevention of Acute ISchemic Events 2 trial
American Heart Journal·2015· 9 cited
Abstract 14643: Apixaban Plus Mono versus Dual Antiplatelet Therapy After Acute Coronary Syndromes: Insights from the APPRAISE-2 Trial
2014· 1 cited
International variation in management and outcomes in high-risk patients following acute coronary syndromes: results from the APPRAISE-2 trial
European Heart Journal·2013Open Access
Apixaban with Antiplatelet Therapy after Acute Coronary Syndrome
New England Journal of Medicine·2011· 995 citedOpen Access
Acute Splenic Infarct in β-Thalassemia Minor: A Novel Combination of Heterozygous β-Globin Mutations with Latent Phenotypes and the Clinical Implications
Hemoglobin·2009· 10 cited
PTEN Expression Causes Feedback Upregulation of Insulin Receptor Substrate 2
Molecular and Cellular Biology·2001· 66 citedOpen Access
Deletion ofPTEN in a patient with Bannayan-Riley-Ruvalcaba syndrome suggests allelism with Cowden disease
American Journal of Medical Genetics·1997· 134 cited
Germline mutations in PTEN are present in Bannayan-Zonana syndrome
Nature Genetics·1997· 654 cited
Germline mutations of the PTEN gene in Cowden disease, an inherited breast and thyroid cancer syndrome
Nature Genetics·1997· 2.1k cited
<i>PTEN</i> , a Putative Protein Tyrosine Phosphatase Gene Mutated in Human Brain, Breast, and Prostate Cancer
Science·1997· 4.8k cited
Comparative Analysis of Smooth Muscle Isoactin Gene Expression in Normal and Neoplastic Tissues
Pathobiology·1997· 13 cited

Frequent Co-authors

John H. Alexander(9), Renato D. Lópes(9), Lars Wallentin(7), Stefan James(6), Shaun G. Goodman(6), Ramon Parsons(5), Robert A. Harrington(5), Harald Darius(4), Megan L. Neely(4), Deepak L. Bhatt(3), Freek W.A. Verheugt(3), Steen Husted(3), Raffaele De Caterina(3), Hisao Ogawa(3), Connie N. Hess(3), Shikha Bose(2), Steven I. Wang(2), Deborah J. Marsh(2), Patricia L. M. Dahia(2), Zimu Zheng(2)